Skip to main content
. 2016 Dec 18;123:34–41. doi: 10.1016/j.rmed.2016.12.010

Table 3.

Characteristics of patients infected with rhinovirus A (RV-A) compared with patients infected with rhinovirus C (RV-C).

RV-A
(n = 23)
RV-C
(n = 10)
p-value
Gender (% females) 74 60 0.42
Age 28 (9) 30 (9) 0.83
Smokers (% never; former; current) 65; 22; 13 80; 0; 20 0.27
Packyears (among former and current smokers) 7 (0.1–17) 1 (0.1–6) 0.29
Atopic (%) 65 60 0.78
ICS dose (daily budesonide eq.) 400 (0–1600) 0 (0–2400) 0.83
FEV1%pred. 77.7 (15.9) 76.2 (17.7) 0.81
FVC %pred. 86.0 (15.0) 87.4 (12.3) 0.80
FeNO (ppb)a 26 (19–36) 38 (25–56) 0.18
ACQ 3.5 (1.3) 3.4 (1.5) 0.98
Blood eosinophils (× 109 cells/L) 0.06 (0–0.52) 0.18 (0.02–1.32) 0.04
Blood neutrophils (× 109 cells/L) 6.3 (2.1–14.1) 6.3 (2.8–11.2) 0.95
Total IgE (× 103 IU/L)a 214 (98–470) 142 (35–574) 0.70
CRP (mg/L)a
9.1 (6.2–13.4)
7.8 (3.3–18.8)
0.56

n = 16
n = 10

Sputum total cell count (× 106/ml)a 0.8 (0.4–1.5) 1.9 (1.0–3.6) 0.06
Sputum eosinophils (× 106/ml)a 0.04 (0.02–0.10) 0.19 (0.09–0.40) 0.01
Sputum %-eosinophilsa 1.1 (0.3–3.4) 1.6 (0.2–11.4) 0.66
Sputum neutrophils (× 106/ml)a 0.3 (0.1–0.8) 1.0 (0.3–3.1) 0.12
Sputum %-neutrophilsa 42.4 (24.7–72.9) 52.5 (29.1–94.4) 0.58
a

Log-transformed and presented as geometric mean (95% CI).